
Postdoctoral researcher @BrighamWomens @harvardmed and @MIT. Focused on immunomodulation using biomaterials.
Boston, MA
Joined October 2012
- Tweets221
- Following1.9K
- Followers223
- Likes1.5K
Pinned Tweet
First paper from my PhD out in @ACS_AMI. Great collaboration between @ImperialNHLI and @impchemistry! Happy to see this work finally published. Thankful for excellent students and academics who worked with me.
pubs.acs.org/doi/full/10.102…
Alex Cryer retweeted
Review with @drphilmol on the contribution of infection and the respiratory microbiome in acute exacerbations of idiopathic pulmonary fibrosis
err.ersjournals.com/content/… – at London, England
If you’re interested in nanotechnology and lung cancer, have a read for free.
Free access to our new review article in Pharmacology & Therapeutics on #nanotechnology and #lung #cancer.
authors.elsevier.com/a/1Z68x… @ELSpharma
Review with @NanoTecResearch on the use of #nanotechnology in #lung #cancer diagnosis and treatment out now.
doi.org/10.1016/j.pharmthera…
Alex Cryer retweeted
So proud of @ErinMGibson, @LiddelowSA et al, who persisted through nearly 7 years of work on this study. "Chemobrain" affects millions of cancer survivors. Through a better understanding of the pathophysiology, new treatment strategies will emerge. #glia
cell.com/cell/fulltext/S0092…
Alex Cryer retweeted
The full peer-reviewed @sciencemagazine evaluation of #AlphaZero is here - a single algorithm that creatively masters chess, shogi and Go through self-play deepmind.com/blog/alphazero-…
Alex Cryer retweeted
Not all the T cells that are intratumoral are necessarily tumor reactive - that number is ~10%.
Might explain why even empirically "hot" tumors have variable response to ICIs. This is also pertinent to ongoing efforts at isolating TILs from solid tumors.
nature.com/articles/s41591-0…
Great news! Life saving work.
Great to announce the SUMMIT study on BBC radio this morning. We will CT screen 25000 people in London for lung cancer and a further 25000 will be invited to help us develop a multi-cancer detection blood test working with a US company GRAIL @Peston @wellcometrust @CRUKresearch
Alex Cryer retweeted
Using AI to help scientists solve big questions is at the core of DeepMind’s mission. Today we’re delighted to announce our first significant milestone: a successful application of machine learning to the protein folding problem. deepmind.com/blog/alphafold/ #AlphaFold (1/5)
Alex Cryer retweeted
In two different mouse models of #cancer, @Regeneron scientists found the dual treatment of PD-1 and GITR antibodies resulted in greater antitumor responses, compared to treatment with either antibody alone: bit.ly/2EZwCI4
Alex Cryer retweeted
In this new Review, Pollard and Cassetta tell us about the different approaches to target and reprogramme pro-tumoural activities of tumour-associated macrophages go.nature.com/2CU3KhP
Alex Cryer retweeted
For this #NationalNanoDay why not read some of our recent nanoscience and nanotechnology books? The first chapter of our professional reference books can be read for free through your Royal Society of Chemistry account rsc.li/1LQ3FLv
Alex Cryer retweeted
BREAKING NEWS:
The Royal Swedish Academy of Sciences has decided to award the #NobelPrize in Chemistry 2018 with one half to Frances H. Arnold and the other half jointly to George P. Smith and Sir Gregory P. Winter.
Alex Cryer retweeted
As a group leader, I'm proud that:
-I am not the most technically proficient person in my lab
-I do not have all of the answers
-The most creative ideas do not come from me
Instead, I coach and mentor an amazing team of people who together drive our innovation and accomplishments
Alex Cryer retweeted
BREAKING NEWS
The Royal Swedish Academy of Sciences has decided to award the #NobelPrize in Physics 2018 “for groundbreaking inventions in the field of laser physics” with one half to Arthur Ashkin and the other half jointly to Gérard Mourou and Donna Strickland.
Alex Cryer retweeted
BREAKING NEWS
The 2018 #NobelPrize in Physiology or Medicine has been awarded jointly to James P. Allison and Tasuku Honjo “for their discovery of cancer therapy by inhibition of negative immune regulation.”
Alex Cryer retweeted
Publication bias and the importance of "negative" results @nytimes nytimes.com/2018/09/24/upsho…
Neural networks and NSCLC, interesting @NatureMedicine article demonstrating diagnostic and predictive ability of AI.
nature.com/articles/s41591-0…
Alex Cryer retweeted
Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA
nature.com/articles/s41551-0…
Alex Cryer retweeted
Live-cell phenotypic-biomarker microfluidic assay for the risk stratification of cancer patients via machine learning
rdcu.be/60RU






















